Literature DB >> 19502677

[Mechanisms of cancer angiogenesis].

Izabela Sacewicz1, Magdalena Wiktorska, Tomasz Wysocki, Jolanta Niewiarowska.   

Abstract

The early stages of tumor growth are independent of blood vessels. When a tumor reaches a volume of approximately 2 mm3, it requires an oxygen and nutrient supply, like other tissues. Satisfaction of the metabolic demands of tumor tissue occurs through neovascularization, which is also called tumor angiogenesis. The best-characterized mechanism of new vessel formation is endothelial cell sprouting. This three-step process involves dilation of a preexisting vessel and basement membrane degradation as well as endothelial cell proliferation and migration, which lead to the restoration of vessel continuity. Eventually, a new vascular basement membrane is deposited and proliferating pericytes are recruited to stabilize the newly formed vessels. Other examples of tumor neovascularization are intussusceptive and glomerular angiogenesis. Since endothelial cell recruitment, proliferation, and migration is not required, they proceed faster and at lower energetic costs. These types of angiogenesis predominate in the colon, stomach, thymus, and skin cancers as well as gliosarcomas mulitiforme. Moreover, tumors can also be fed by co-opting host vessels or by forming "pseudovessels" in angiogenesis mimicry. All the processes mentioned in this review are not mutually exclusive; on the contrary, they are closely connected in many cases.Therefore, effective anticancer therapies should not only focus on diminishing the activity of proangiogenic factors targeted during vessel sprouting, but include the great variety of vessel factors.

Entities:  

Mesh:

Year:  2009        PMID: 19502677

Source DB:  PubMed          Journal:  Postepy Hig Med Dosw (Online)        ISSN: 0032-5449            Impact factor:   0.270


  9 in total

Review 1.  Alpha-Ketoglutarate as a Molecule with Pleiotropic Activity: Well-Known and Novel Possibilities of Therapeutic Use.

Authors:  Barbara Zdzisińska; Aleksandra Żurek; Martyna Kandefer-Szerszeń
Journal:  Arch Immunol Ther Exp (Warsz)       Date:  2016-06-20       Impact factor: 4.291

2.  The effect of piperlongumine on endothelial and lung adenocarcinoma cells with regulated expression of profilin-1.

Authors:  Maciej Gagat; Marta Hałas-Wiśniewska; Wioletta Zielińska; Magdalena Izdebska; Dariusz Grzanka; Alina Grzanka
Journal:  Onco Targets Ther       Date:  2018-11-22       Impact factor: 4.147

3.  Using a Classifier Fusion Strategy to Identify Anti-angiogenic Peptides.

Authors:  Lina Zhang; Runtao Yang; Chengjin Zhang
Journal:  Sci Rep       Date:  2018-09-14       Impact factor: 4.379

4.  AGTR1 promotes lymph node metastasis in breast cancer by upregulating CXCR4/SDF-1α and inducing cell migration and invasion.

Authors:  Yuxi Ma; Zihan Xia; Chunmei Ye; Chong Lu; Sheng Zhou; Juan Pan; Cuiwei Liu; Jieying Zhang; Tao Liu; Ting Hu; Linka Xie; Gang Wu; Yanxia Zhao
Journal:  Aging (Albany NY)       Date:  2019-06-19       Impact factor: 5.682

Review 5.  The Role of Periostin in Angiogenesis and Lymphangiogenesis in Tumors.

Authors:  Adrian Wasik; Katarzyna Ratajczak-Wielgomas; Arkadiusz Badzinski; Piotr Dziegiel; Marzenna Podhorska-Okolow
Journal:  Cancers (Basel)       Date:  2022-08-30       Impact factor: 6.575

6.  High concentration of urokinase-type plasminogen activator receptor in the serum of women with primary breast cancer.

Authors:  Anna Thielemann; Aleksandra Baszczuk; Przemysław Kopczyński; Zygmunt Kopczyński
Journal:  Contemp Oncol (Pozn)       Date:  2013-11-14

7.  Influence of Adalimumab on the Expression Profile of Genes Associated with the Histaminergic System in the Skin Fibroblasts In Vitro.

Authors:  Dominika Wcisło-Dziadecka; Beniamin Grabarek; Nikola Zmarzły; Aleksandra Skubis; Bartosz Sikora; Celina Kruszniewska-Rajs; Joanna Gola; Urszula Mazurek; Eugeniusz Kucharz
Journal:  Biomed Res Int       Date:  2018-01-02       Impact factor: 3.411

8.  Improved anticancer activity of betulinic acid on breast cancer through a grafted copolymer-based micelles system.

Authors:  Xueju Qi; Cong Gao; Chuanjin Yin; Junting Fan; Xiaochen Wu; Chuanlong Guo
Journal:  Drug Deliv       Date:  2021-12       Impact factor: 6.419

9.  Elevated YKL-40 serum levels may contribute to wet age-related macular degeneration via the ERK1/2 pathway.

Authors:  Yue Bin; Yanyao Liu; Shaoqiu Jiang; Hui Peng
Journal:  FEBS Open Bio       Date:  2021-09-30       Impact factor: 2.693

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.